Outcomes of bendamustine- or cyclophosphamide-based first-line chemotherapy in older patients with indolent B-cell lymphoma. – PubMed – NCBI

Am J Hematol. 2019 Dec 17. doi: 10.1002/ajh.25707. [Epub ahead of print]

Read the full article here

Related Articles